Last reviewed · How we verify

Fixed opioid prescription

The George Washington University Biostatistics Center · Phase 3 active Small molecule

A fixed-dose opioid formulation designed to provide consistent pain relief through standardized dosing of opioid analgesics.

A fixed-dose opioid formulation designed to provide consistent pain relief through standardized dosing of opioid analgesics. Used for Chronic pain management (specific indication not detailed in available information).

At a glance

Generic nameFixed opioid prescription
SponsorThe George Washington University Biostatistics Center
Drug classOpioid analgesic
ModalitySmall molecule
Therapeutic areaPain Management
PhasePhase 3

Mechanism of action

Fixed opioid prescriptions combine predetermined doses of opioid medications to optimize pain management while attempting to reduce dosing variability and improve compliance. This approach is typically used in chronic pain management where consistent opioid exposure is therapeutically desired, though modern practice emphasizes careful patient selection and monitoring due to addiction and overdose risks.

Approved indications

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape: